Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Trevor L. Hoffman is active.

Publication


Featured researches published by Trevor L. Hoffman.


Journal of Virology | 2001

Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein

Terri G. Edwards; Trevor L. Hoffman; Frédéric Baribaud; Stéphanie Wyss; Celia C. LaBranche; Josephine Romano; Joshua Adkinson; Matthew Sharron; James A. Hoxie; Robert W. Doms

ABSTRACT A CD4-independent version of the X4 human immunodeficiency virus type 1 (HIV-1) HXBc2 envelope (Env) protein, termed 8x, mediates infection of CD4-negative, CXCR4-positive cells, binds directly to CXCR4 in the absence of CD4 due to constitutive exposure of a conserved coreceptor binding site in the gp120 subunit, and is more sensitive to antibody-mediated neutralization. To study the relationships between CD4 independence, neutralization sensitivity, and exposure of CD4-induced epitopes associated with the coreceptor binding site, we generated a large panel of Env mutants and chimeras between 8x and its CD4-dependent parent, HXBc2. We found that a frameshift mutation just proximal to the gp41 cytoplasmic domain in 8x Env was necessary but not sufficient for CD4 independence and led to increased exposure of the coreceptor binding site. In the presence of this altered cytoplasmic domain, single amino acid changes in either the 8x V3 (V320I) or V4/C4 (N386K) regions imparted CD4 independence, with other changes playing a modulatory role. The N386K mutation resulted in loss of an N-linked glycosylation site, but additional mutagenesis showed that it was the presence of a lysine rather than loss of the glycosylation site that contributed to CD4 independence. However, loss of the glycosylation site alone was sufficient to render Env neutralization sensitive, providing additional evidence that carbohydrate structures shield important neutralization determinants. Exposure of the CD4-induced epitope recognized by monoclonal antibody 17b and which overlaps the coreceptor binding site was highly sensitive to an R298K mutation at the base of the V3 loop and was often but not always associated with CD4 independence. Finally, while not all neutralization-sensitive Envs were CD4 independent, all CD4-independent Envs exhibited enhanced sensitivity to neutralization by HIV-1-positive human sera, indicating that the humoral immune response can exert strong selective pressure against the CD4-independent phenotype in vivo. Whether this can be used to advantage in designing more effective immunogens remains to be seen.


Journal of Virology | 2000

Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1

Theodore C. Pierson; Trevor L. Hoffman; Joel N. Blankson; Diana Finzi; Karen Chadwick; Joseph B. Margolick; Christopher B. Buck; Janet D. Siliciano; Robert W. Doms; Robert F. Siliciano

ABSTRACT Latently infected resting CD4+ T cells provide a long-term reservoir for human immunodeficiency virus type 1 (HIV-1) and are likely to represent the major barrier to virus eradication in patients on combination antiretroviral therapy. The mechanisms by which viruses enter the latent reservoir and the nature of the chemokine receptors involved have not been determined. To evaluate the phenotype of the virus in this compartment with respect to chemokine receptor utilization, full-length HIV-1 env genes were cloned from latently infected cells and assayed functionally. We demonstrate that the majority of the viruses in the latent reservoir utilize CCR5 during entry, although utilization of several other receptors, including CXCR4, was observed. No alternative coreceptors were shown to be involved in a systematic fashion. Although R5 viruses are present in the latent reservoir, CCR5 was not expressed at high levels on resting CD4+ T cells. To understand the mechanism by which R5 viruses enter latent reservoir, the ability of an R5 virus, HIV-1 Ba-L, to infect highly purified resting CD4+ T lymphocytes from uninfected donors was evaluated. Entry of Ba-L could be observed when virus was applied at a multiplicity approaching 1. However, infection was limited to a subset of cells expressing low levels of CCR5 and markers of immunologic memory. Naive cells could not be infected by an R5 virus even when challenged with a large inoculum. Direct cell fractionation studies showed that latent virus is present predominantly in resting memory cells but also at lower levels in resting naive cells. Taken together, these findings provide support for the hypothesis that the direct infection of naive T cells is not the major mechanism by which the latent infection of resting T cells is established.


Molecular Membrane Biology | 1999

HIV-1 envelope determinants for cell tropism and chemokine receptor use

Trevor L. Hoffman; Robert W. Doms

Isolates of human immunodeficiency virus type-1 (HIV-1) display marked differences in their ability to replicate in macrophages and transformed T-cell lines in vitro, a property that has important implications for disease pathogenesis. The restriction in replication between these two CD4-positive cell types is largely at the level of viral entry and is regulated by the viral envelope (env) gene. The envelope protein (Env) is responsible for fusion of the viral and host membranes, and a particular region of Env called the V3-loop has been implicated in regulating viral tropism. However, other regions of Env, such as the V1- and V2-loops, have been shown to modulate the effects of the V3-loop. The discovery that Env initially binds the CD4 molecule on the target cell surface and then makes subsequent interactions with one of several members of the chemokine receptor family has greatly enhanced the molecular understanding of HIV-1 entry. The differential use of chemokine receptors by different viral isolates and their expression in different cell types largely explains viral tropism. The same regions in Env responsible for virus tropism have also been shown to play an important role in mediating chemokine receptor use. The recent crystallization of HIV-1 Env in complex with CD4 illuminates the architecture of the components involved in mediating fusion between the viral and host membranes. The spatial relationship between variable structures of Env previously implicated in tropism and chemokine receptor use and conserved Env structures potentially involved in chemokine receptor binding are discussed.


The Journal of Infectious Diseases | 1997

CCR5 Genotypes in Sexually Active Couples Discordant for Human Immunodeficiency Virus Type 1 Infection Status

Trevor L. Hoffman; Rob Roy MacGregor; Harold Burger; Rosemarie Mick; Robert W. Doms; Ronald G. Collman

Persons who are homozygous for the delta32 polymorphism of the CCR5 chemokine receptor gene are highly protected against human immunodeficiency virus type 1 (HIV-1) infection. Previous studies described 54 HIV-1-discordant couples in whom no virus transmission occurred despite extensive sexual contact. The possible role of the delta32 polymorphism in the lack of HIV-1 transmission between these partners was studied. No participants were homozygous for the delta32 allele, but the proportion that was heterozygous was higher among HIV-1-seronegative than HIV-1-seropositive partners (28% vs. 11%, P = .05). This association was seen in heterosexual couples (P = .03) but not in homosexual couples (P = .74). Among white persons, who are most likely to carry the delta32 allele, 38.9% of HIV-1-uninfected and 5.6% of HIV-1-infected heterosexual partners were heterozygous (P = .04). These data are consistent with a possible association between the heterozygous delta32 genotype in heterosexual sex partners and partial protection against HIV-1 infection, and they emphasize the importance of analyzing different risk groups in studies of host factors that influence infection.


AIDS Research and Human Retroviruses | 2001

Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression

James F. Demarest; Noreen Jack; Farley R. Cleghorn; Michael L. Greenberg; Trevor L. Hoffman; Janet Ottinger; Lori E. Fantry; Jeffrey Edwards; Thomas R. O'Brien; Kai Cao; Bisram Mahabir; William A. Blattner; Courtenay Bartholomew; Kent J. Weinhold

The immunologic and virologic factors that impact on the rate of disease progression after acute infection with human immunodeficiency virus (HIV) type 1 are poorly understood. A patient with an extraordinarily rapid disease course leading to AIDS-associated death within 6 months of infection was studied intensively for the presence of anti-HIV immune reactivities as well as changes in the genetic and biologic properties of virus isolates. Although altered humoral responses were evident, the most distinctive immunologic feature was a nearly complete absence of detectable HIV-specific CTL responses. In addition to a rapid decline in CD3+CD4+ cells, elevated percentages of CD8+CD45RA+ and CD8+CD57+ cells and diminished CD8+CD45R0+ and CD8+CD28+ cells were evident. Primary viral isolates recovered throughout the course of infection exhibited limited sequence diversity. Cloned viral envelopes were found to have unusually broad patterns of coreceptor usage for cell-cell fusion, although infectivity studies yielded no evidence of infection via these alternative receptors. The infectivity studies demonstrated that these isolates and their envelopes maintained an R5 phenotype throughout the course of disease. The absence of demonstrable anti-HIV CTL reactivities, coupled with a protracted course of seroconversion, highlights the importance of robust HIV-specific immune responses in the control of disease progression.


Proceedings of the National Academy of Sciences of the United States of America | 1999

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

Trevor L. Hoffman; Celia C. LaBranche; Wentao Zhang; Gabriella Canziani; James I. Robinson; Irwin M. Chaiken; James A. Hoxie; Robert W. Doms


Proceedings of the National Academy of Sciences of the United States of America | 1997

CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain

Aimee L. Edinger; Joseph L. Mankowski; Benjamin J. Doranz; Barry J. Margulies; Benhur Lee; Joseph Rucker; Matthew Sharron; Trevor L. Hoffman; Joanne F. Berson; M. Christine Zink; Vanessa M. Hirsch; Janice E. Clements; Robert W. Doms


Journal of Virology | 1999

Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions

Benjamin J. Doranz; Michael J. Orsini; Julie D. Turner; Trevor L. Hoffman; Joanne F. Berson; James A. Hoxie; Stephen C. Peiper; Lawrence F. Brass; Robert W. Doms


Journal of Virology | 1998

An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

Aimee L. Edinger; Trevor L. Hoffman; Matthew Sharron; Benhur Lee; Yanji Yi; Wonkyu Choe; Dennis L. Kolson; Branka Mitrovic; Yiqing Zhou; Daryl Faulds; Ronald G. Collman; Joseph Hesselgesser; Richard Horuk; Robert W. Doms


Virology | 1998

Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.

Aimee L. Edinger; Trevor L. Hoffman; Matthew Sharron; Benhur Lee; Brian F. O'Dowd; Robert W. Doms

Collaboration


Dive into the Trevor L. Hoffman's collaboration.

Top Co-Authors

Avatar

Robert W. Doms

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph Rucker

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dennis L. Kolson

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Matthew Sharron

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Michael J. Endres

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Paul Bates

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Benhur Lee

Icahn School of Medicine at Mount Sinai

View shared research outputs
Researchain Logo
Decentralizing Knowledge